UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and efficacy of abiraterone acetate plus prednisolone in patients with castration-resistant prostate cancer: a prospective, observational, post-marketing surveillance study

Japanese journal of clinical oncology, 2021-09, Vol.51 (9), p.1452-1461

2021

Volltextzugriff (PDF)

Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study

BMC urology, 2020-09, Vol.20 (1), p.139-139, Article 139

2020

Volltextzugriff (PDF)

An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer

International journal of clinical oncology, 2019-12, Vol.24 (12), p.1596-1604

2019

Volltextzugriff (PDF)

Patient Preferences and Urologist Judgments on Prostate Cancer Therapy in Japan

American journal of men's health, 2018-07, Vol.12 (4), p.1094-1101

2018

Volltextzugriff (PDF)

A phase 2 trial of abiraterone acetate in Japanese men with metastatic castration-resistant prostate cancer and without prior chemotherapy (JPN-201 study)

Japanese journal of clinical oncology, 2014-12, Vol.44 (12), p.1216-1226

2014

Volltextzugriff (PDF)

Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 study

Prostate international, 2020-12, Vol.8 (4), p.190-197

2020

Volltextzugriff (PDF)

Correction to: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study

BMC urology, 2020-10, Vol.20 (1), p.166-166, Article 166

2020

Volltextzugriff (PDF)

A phase 2 study of abiraterone acetate in Japanese men with metastatic castration-resistant prostate cancer who had received docetaxel-based chemotherapy

Japanese journal of clinical oncology, 2014-12, Vol.44 (12), p.1206-1215

2014

Volltextzugriff (PDF)

Association of early PSA decline and time to PSA progression in abiraterone acetate-treated metastatic castration-resistant prostate cancer; a post-hoc analysis of Japanese phase 2 trials

BMC urology, 2016-06, Vol.16 (1), p.27-27, Article 27

2016

Volltextzugriff (PDF)

Burden of illness of chemotherapy in castration-resistant prostate cancer patients in Japan: a retrospective database analysis

Current medical research and opinion, 2018-10, Vol.34 (10), p.1855-1860

2018

Volltextzugriff (PDF)

MO29-6 Safety and tolerability of lazertinib and in combination with amivantamab in advanced EGFR-mutated Japanese NSCLC

Annals of oncology, 2021-07, Vol.32, p.S317-S317

2021

Volltextzugriff (PDF)

Two placebo-controlled, randomized withdrawal studies to evaluate the fentanyl 1 day patch in opioid-naïve patients with chronic pain

Current medical research and opinion, 2015-12, Vol.31 (12), p.2207-2218

2015

Volltextzugriff (PDF)

Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain

Current medical research and opinion, 2013-10, Vol.29 (10), p.1399-1409

2013

Volltextzugriff (PDF)

Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release

Clinical drug investigation, 2014-07, Vol.34 (7), p.501-511

2014

Volltextzugriff (PDF)

Adverse event reporting in the recent study by Imanaka et al. describing the efficacy and safety of tapentadol extended release for tumor-related pain

Current medical research and opinion, 2014-09, Vol.30 (9), p.1909-1910

2014

Volltextzugriff (PDF)

8-week Safety Profile of Tapentadol Extended Release Tablets Switched from Other Opioids for Well-controlled, Moderate to Severe, Chronic Malignant Tumor-related Pain: Constipation, Nausea, Vomiting and Somnolence

Palliative Care Research, 2016, Vol.11(1), pp.116-122

2016

Volltextzugriff (PDF)

A Multicenter, Open-label Study of Tapentadol Extended-release Tablets in Opioid-naïve and Opioid-switching Subjects with Moderate to Severe Cancer Pain

Palliative Care Research, 2016, Vol.11(2), pp.147-155

2016

Volltextzugriff (PDF)

A Multicenter, Open-label Study of Tapentadol Extended-release Tablets in Opioid-naïve and Opioid-switching Subjects with Moderate to Severe Cancer Pain

Palliative care research, 2016, Vol.11 (2), p.147-155

2016

Volltextzugriff (PDF)

タペンタドール徐放錠の中等度から高度の癌性疼痛を有するオピオイド新規導入患者およびオピオイド切り替え患者を対象とした多施設共同非盲検試験

Palliative Care Research, 2016, Vol.11(2), pp.147-155

2016

Volltextzugriff (PDF)

中等度から高度のがん疼痛に対し，他のオピオイド鎮痛薬の定時投与からタペンタドール徐放錠8週間投与に切り替えた時の安全性プロファイル─便秘，悪心，嘔吐，傾眠の検討

Palliative Care Research, 2016, Vol.11(1), pp.116-122

2016

Volltextzugriff (PDF)

CONSERVATIVE SURGERY FOR RENAL CELL CARCINOMA

Nippon Hinyokika Gakkai zasshi, 1994, Vol.85 (3), p.446-451

1994

Volltextzugriff (PDF)

CONSERVATIVE SURGERY FOR RENAL CELL CARCINOMA

The Japanese Journal of Urology, 1994/03/20, Vol.85(3), pp.446-451

1994

Volltextzugriff (PDF)

COMPUTED TOMOGRAPHY IN THE DIAGNOSIS OF TRANSITIONAL CELL CARCINOMA OF THE RENAL PELVIS

The Japanese Journal of Urology, 1993/10/20, Vol.84(10), pp.1835-1838

1993

Volltextzugriff (PDF)

A Clinical Study of Percutaneous Nephrouretero Lithotripsy be A New Ultrasound Lithotriptor

JAPANES JOURNAL OF MEDICAL INSTRUMENTATION, 1987-12, Vol.57 (12), p.578-580

1987

Volltextzugriff (PDF)

EARLY CHANGES OF SERUM α-FETOPROTEIN AFTER CHEMOTHERAPY IN ADVANCED TESTICULAR TUMORS

The Japanese Journal of Urology, 1990/07/20, Vol.81(7), pp.1010-1016

1990

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(40)
Tagungsberichte
(1)

Sprache

Englisch
(25)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

Humans
(16)
Male
(16)
Middle Aged
(14)
Science & Technology
(14)
Life Sciences & Biomedicine
(13)
Aged
(12)
Female
(8)
Adult
(7)
Aged, 80 And Over
(6)
Chemotherapy
(6)
Original
(6)
Urology
(6)
Opioid
(5)
Prostate Cancer
(5)
Prostatic Neoplasms, Castration-Resistant - Drug Therapy
(5)
Tapentadol
(5)
Abiraterone Acetate
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Chronic Pain - Drug Therapy
(4)
General & Internal Medicine
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of abiraterone acetate plus prednisolone in patients with castration-resistant prostate cancer: a prospective, observational, post-marketing surveillance study

Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study

An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer

Patient Preferences and Urologist Judgments on Prostate Cancer Therapy in Japan

A phase 2 trial of abiraterone acetate in Japanese men with metastatic castration-resistant prostate cancer and without prior chemotherapy (JPN-201 study)

Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 study

Correction to: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study

A phase 2 study of abiraterone acetate in Japanese men with metastatic castration-resistant prostate cancer who had received docetaxel-based chemotherapy

Association of early PSA decline and time to PSA progression in abiraterone acetate-treated metastatic castration-resistant prostate cancer; a post-hoc analysis of Japanese phase 2 trials

Burden of illness of chemotherapy in castration-resistant prostate cancer patients in Japan: a retrospective database analysis

MO29-6 Safety and tolerability of lazertinib and in combination with amivantamab in advanced EGFR-mutated Japanese NSCLC

Two placebo-controlled, randomized withdrawal studies to evaluate the fentanyl 1 day patch in opioid-naïve patients with chronic pain

Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain

Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release

Adverse event reporting in the recent study by Imanaka et al. describing the efficacy and safety of tapentadol extended release for tumor-related pain

8-week Safety Profile of Tapentadol Extended Release Tablets Switched from Other Opioids for Well-controlled, Moderate to Severe, Chronic Malignant Tumor-related Pain: Constipation, Nausea, Vomiting and Somnolence

A Multicenter, Open-label Study of Tapentadol Extended-release Tablets in Opioid-naïve and Opioid-switching Subjects with Moderate to Severe Cancer Pain

A Multicenter, Open-label Study of Tapentadol Extended-release Tablets in Opioid-naïve and Opioid-switching Subjects with Moderate to Severe Cancer Pain

タペンタドール徐放錠の中等度から高度の癌性疼痛を有するオピオイド新規導入患者およびオピオイド切り替え患者を対象とした多施設共同非盲検試験

中等度から高度のがん疼痛に対し，他のオピオイド鎮痛薬の定時投与からタペンタドール徐放錠8週間投与に切り替えた時の安全性プロファイル─便秘，悪心，嘔吐，傾眠の検討

CONSERVATIVE SURGERY FOR RENAL CELL CARCINOMA

CONSERVATIVE SURGERY FOR RENAL CELL CARCINOMA

COMPUTED TOMOGRAPHY IN THE DIAGNOSIS OF TRANSITIONAL CELL CARCINOMA OF THE RENAL PELVIS

A Clinical Study of Percutaneous Nephrouretero Lithotripsy be A New Ultrasound Lithotriptor

EARLY CHANGES OF SERUM α-FETOPROTEIN AFTER CHEMOTHERAPY IN ADVANCED TESTICULAR TUMORS

Suchergebnisse filtern